RAD51 and XRCC3 polymorphisms: Impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ–MYH11(+) acute myeloid leukemia
- Resource Type
- Article
- Source
- In
Leukemia Research August 2011 35(8):1020-1026 - Subject
- Language
- ISSN
- 0145-2126